Table 1.
Clinical characteristics of study participants with type 2 diabetes (n = 24)
| Age, years | 56.2 ± 8.9 |
| Gender, male/female | 14/10 |
| Body mass index, kg/m2 | 26.7 ± 4.2 |
| Duration of diabetes, years | 5.3 ± 6.8 |
| Systolic blood pressure, mmHg | 122.6 ± 12.0 |
| Diastolic blood pressure, mmHg | 76.3 ± 11.0 |
| Diabetes-related complications | |
| Neuropathy, n (%) | 9 (37.0) |
| Retinopathy, n (%) | 7 (29.0) |
| Nephropathy, n (%) | 6 (25.0) |
| Fasting glucose, mmol/L | 177.0 ± 56.0 |
| IRI, μU/mL | 9.3 ± 6.4 |
| HbA1c, % | 10.1 ± 2.4 |
| Urinary CPR, μg/day | 109.9 ± 61.2 |
| AST, U/L | 26.0 ± 12.3 |
| ALT, U/L | 28.1 ± 14.1 |
| eGFR, mL/min/1.73 m2 | 86.1 ± 18.5 |
| Uric acid, mg/dL | 5.3 ± 1.3 |
Data are mean ± SD or n (%)
IRI immunoreactive insulin, HbA1c glycated hemoglobin, CPR C peptide immunoreactivity, eGFR estimated glomerular filtration rate